Keywords
AntidepressantKetamineAction (physics)PsychologyNeuroscienceMedicinePharmacologyPsychiatryHippocampus
Affiliated Institutions
Related Publications
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Depression is a multicausal disorder and has been associated with the risk to develop cancer, dementia, diabetes, epilepsy and stroke. As a metabolic disorder depression has bee...
Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder
In this 8-week double-blind multicenter trial, we evaluated the efficacy and safety of 2 fixed doses of agomelatine in patients with moderate to severe major depressive disorder...
From inflammation to sickness and depression: when the immune system subjugates the brain
In response to a peripheral infection, innate immune cells produce pro-inflammatory cytokines that act on the brain to cause sickness behaviour. When activation of the periphera...
Publication Info
- Year
- 2018
- Type
- review
- Volume
- 23
- Issue
- 4
- Pages
- 801-811
- Citations
- 1012
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1012
OpenAlex
Cite This
Panos Zanos,
Todd D. Gould
(2018).
Mechanisms of ketamine action as an antidepressant.
Molecular Psychiatry
, 23
(4)
, 801-811.
https://doi.org/10.1038/mp.2017.255
Identifiers
- DOI
- 10.1038/mp.2017.255